arXiv preprint ·

Discovery of new antiviral agents through artificial intelligence: in vitro and in vivo results

Roza Izmailyan, Mher Matevosyan, Hamlet Khachatryan, Anastasiya Shavina, Smbat Gevorgyan, Artur Ghazaryan, Irina Tirosyan, Yeva Gabrielyan, Marusya Ayvazyan, Boris Martirosyan, Vardan Harutyunyan and Hovakim Zakaryan

Published
Source
arXiv preprint, posted before peer review
DOI
10.1016/j.antiviral.2024.105818
Original
Read it at arXiv
Topics
BiomoleculesMachine Learning

Abstract

In this research, we employed a deep reinforcement learning (RL)-based molecule design platform to generate a diverse set of compounds targeting the neuraminidase (NA) of influenza A and B viruses. A total of 60291 compounds were generated, of which 86.5% displayed superior physicochemical properties compared to oseltamivir. After narrowing down the selection through computational filters, nine compounds with non-sialic acid-like structures were selected for in vitro experiments. We identified two compounds, DS-22-inf-009 and DS-22-inf-021 that effectively inhibited the NAs of both influenza A and B viruses (IAV and IBV), including H275Y mutant strains at low micromolar concentrations. Molecular dynamics simulations revealed a similar pattern of interaction with amino acid residues as oseltamivir. In cell-based assays, DS-22-inf-009 and DS-22-inf-021 inhibited IAV and IBV in a dose-dependent manner with EC50 values ranging from 0.29 uM to 2.31 uM. Furthermore, animal experiments showed that both DS-22-inf-009 and DS-22-inf-021 exerted antiviral activity in mice, conferring 65% and 85% protection from IAV (H1N1 pdm09), and 65% and 100% protection from IBV (Yamagata lineage), respectively. Thus, these findings demonstrate the potential of RL to generate compounds with promising antiviral properties.

The authors’ abstract, as arXiv lists it. arXiv’s listings, abstracts included, are free for anyone to reuse.

Read it on ReadSearch

Each opens after you create an account, and brings you back to this paper.

Already a reader? Sign in

All new papers in Biomolecules

Get the few papers worth your time in Biomolecules every morning.

ReadSearch reads the new papers in your field each day and brings you the few worth reading, each with its key finding in a sentence.

Papers belong to their authors and publishers; every page here links to the original. All research topics